OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

JOHNSON + JOHNSON DL 1/  US4781601046  /

Quotrix
09/01/2025  16:29:27 Chg. +0.9600 Volume Bid17:02:43 Ask17:02:43 Market Capitalization Dividend Y. P/E Ratio
138.4600EUR +0.70% 347
Turnover: 47,966.8000		 138.0200Bid Size: 190 138.4600Ask Size: 190 330.95 bill.EUR - -
TeleTrader 02/01 J&J announces dividend for Q1 2025
TeleTrader 15/10/2024 J&J's Q3 sales rise by 5.2% to $22.5B
TeleTrader 01/10/2024 J&J: Over $2B to be put into new facility in North Carolina
TeleTrader 10/09/2024 D. S. Davis retires as director of Johnson & Johnson
TeleTrader 20/08/2024 Johnson & Johnson to buy V-Wave for up to $1.7B
GlobeNewswire 14/08/2024 BlueSphere Bio Accepted as Member of Johnson & Johnson Innovation-JLABS
TeleTrader 17/07/2024 J&J's Q2 sales up by 4.3% to $22.4 billion
GlobeNewswire 28/05/2024 Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey ...
TeleTrader 01/05/2024 J&J to pay $6.5 billion to settle US talc-related lawsuits
GlobeNewswire 17/04/2024 TRC Amends Its Tender Offer for Johnson & Johnson
GlobeNewswire 10/04/2024 SWAV Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Shockwave Medical t...
TeleTrader 05/04/2024 J&J to acquire Shockwave Medical for $13.1B
TeleTrader 26/03/2024 J&J may allegedly acquire Shockwave Medical
GlobeNewswire 15/03/2024 CURE Media Group and Oncology Nursing News Announces the 2024 Extraordinary Healer® Award Finalists
GlobeNewswire 06/03/2024 Ambrx Shareholders Approve Acquisition by Johnson & Johnson
TeleTrader 27/01/2024 J&J, Merck CEOs to testify before Senate on drug prices
TeleTrader 24/01/2024 J&J to pay $149.5M to settle Washington state opioid case
TeleTrader 23/01/2024 J&J to pay $700M in talc powder probe settlement
TeleTrader 23/01/2024 J&J's Q4 sales top estimates, up 7.3% to $21.4B
TeleTrader 23/01/2024 Johnson & Johnson Q4 earnings preview
TeleTrader 22/01/2024 Earnings preview: Tesla takes center stage
TeleTrader 08/01/2024 J&J to buy biotech company Ambrx for $2B
GlobeNewswire 04/12/2023 Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovat...
GlobeNewswire 04/12/2023 Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovat...
TeleTrader 07/11/2023 J&J to begin trials with surgical robot